Bicycle Therapeutics’ (BCYC) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a report issued on Wednesday,Benzinga reports. The firm currently has a $33.00 price target on the stock. HC Wainwright also issued estimates for Bicycle Therapeutics’ Q1 2025 earnings at ($0.99) EPS, Q2 2025 earnings at ($0.99) EPS, FY2025 earnings […]
HC Wainwright reiterated their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a report issued on Wednesday,Benzinga reports. The firm currently has a $33.00 price target on the stock. HC Wainwright also issued estimates for Bicycle Therapeutics’ Q1 2025 earnings at ($0.99) EPS, Q2 2025 earnings at ($0.99) EPS, FY2025 earnings […]
